Contact us : info@bioworlde.com
Home > Product > Antigen-Peptide
Claudin-3 (T204) Peptide BS1067P
Product NameClaudin-3 (T204) Peptide
Catalog No.BS1067P
ApplicationsBlocking
Swiss-ProtO15551
Product1 mg/ml in DI water.
Purification&PuritySynthetic peptide Claudin-3 (T204). (Note: the amino acid sequence is proprietary). The purity is > 98%.
Storage&StabilityStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
SpecificityThis peptide can be used with studies using BS1067 Claudin-3 (T204) pAb.
Browse similar products>>
Size Price
1mg $368
Add to cart My orders
Product Name :
Claudin-3 (T204) Peptide
Applications :
Blocking
Background :
Claudins, which consist of four transmembrane domains and two extracellular loops, make up tight junction strands. Claudin expression is highly restricted to specfic regions of different tissues and variations of Claudin expression may have an important role in transcellular transport through tight junctions. In rat liver, claudin-3 is uniformly expressed, whereas in the pancreas, claudin-3 is expressed in junctions of the duct epithelia and junctions of acinar cells. Claudin-3 binds the peptide toxin Clostridium perfringens enterotoxin (CPE) at the cell surface via the second extracellular loop of claudin-3. The gene encoding human claudin-3 maps to chromosome 7q11.23.
Alternative Name :
Claudin3; Claudin 3; Clostridium perfringens enterotoxin receptor 2; CPE-R 2; CPE-receptor 2; Rat ventral prostate.1 protein homolog; hRVP1; CLDN3; C7orf1; CPETR2; CPE R2; CPER2;
Swiss-Prot :
O15551
Product :
1 mg/ml in DI water.
Purification&Purity :
Synthetic peptide Claudin-3 (T204). (Note: the amino acid sequence is proprietary). The purity is > 98%.
Storage&Stability :
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Specificity :
This peptide can be used with studies using BS1067 Claudin-3 (T204) pAb.
Blocking peptide available as BS1067PP
COPYRIGHT © 2015-2018 Bioworld Technology, Inc. All rights reserved POLYCLONAL AND MONOCLONAL ANTIBODY CENTER